AI and government deals lift GF, but valuation and rate worries cap gains
US government backing and CHIPS award The US took a $300M equity stake (~1% ownership) and awarded GF $300M in CHIPS Act funds for silicon photonics, strengthening its finances and validating its role in domestic chip production.
This is a major new government endorsement that boosts GF's credibility and resources.
Major customer and partnership deals GF signed a $2B TSMC interposer agreement, a $375M quantum award, Marvell SiGe capacity deal, and Cirrus Logic commitments through 2028, expanding its AI, quantum, and specialty chip business.
These deals represent significant new revenue streams and partnerships that drive growth.
Japan-US talks for new plant Japan and the US are discussing a $13–19B GF plant that could add huge long-term capacity, signaling strong government support and potential future growth.
This potential plant is a new development that could significantly expand GF's manufacturing footprint.
Valuation and rate concerns BNP Paribas downgraded GFS to Neutral (target cut to $51 from $80), citing priced-in growth after a 44% one-year gain; the Fed's rate hike to 3.75–4.00% pressures richly valued chip stocks.
This explains the main counterweight to the positive news, highlighting risks that could limit stock performance.